advanced search
Cecile Gross
Global Category Manager, Parenteral
Nemera

Is this your profile?

About

Cécile Gross is Marketing Global Category Manager at Nemera, focusing on parenteral devices. She oversees the product portfolio strategy, development and lifecycle for safety system, pen injector and on-body injector platforms.

Ms Gross has more than two decades of experience in the medical device industry, marketing business-to-business technological products and implementing product lifecycle management for various kinds of devices. A graduate in International Business, she completed her initial training with a master’s degree in Marketing and Management in the Healthcare Industry at the IMIS Institute (Lyon, France).

Contributions

INJECTION
ADDRESSING DIABESITY WITH PEN INJECTOR PLATFORMS
 Cécile Gross and Mark Tunkel discuss the variety of pen injector platforms to meet the different needs of diabetes patients.

More contributions

CONNECTIVITY
HOW TO NAVIGATE A COMPLEX CONNECTIVITY ENVIRONMENT
Pascal Dugand, Cécile Gross and Mark Tunkel consider the complexity of the landscape for connected devices and demonstrate how a balance can be achieved between patient needs, technology and the cost of integrating this technology into a device.
WEARABLES
CHRONIC PATIENTS AT THE CENTRE OF LARGE-VOLUME SC DELIVERY WITH A SUSTAINABLE ON-BODY INJECTOR
Cécile Gross and Mark Tunkel discuss the role of patient-centricity in the development of Nemera’s sustainable on-body injector platform.
INJECTION
ADDRESSING PEPTIDE THERAPEUTICS WITH A VERSATILE PEN PLATFORM
Cécile Gross and Mark Tunkel discuss the rising demand in peptide therapeutics and how Nemera’s PenVario pen injector platform, coupled with Nemera’s end-to-end service offering, has been designed to help pharma partners achieve success in this sector.
CONNECTIVITY
PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT
Mark Tunkel and Cécile Gross consider the development of connected drug delivery devices and identify how understanding the patient journey from diagnosis to treatment can be used as an early-stage decision-making tool.
#138_2022_Oct_Nemera_Featured
PREFILLED SYRINGES
A HIGH-QUALITY AND ROBUST SAFETY SYSTEM FOR HIGH-VOLUME BIOLOGICS AT HOME
Audrey Chandra and Cécile Gross discuss Nemera’s development of a new product for the safe delivery of high-volume biologics at home.
#137_Sept2022_Nemera_Feature
WEARABLES
OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS
Cécile Gross discusses the unmet drug delivery needs in chronic diseases, and details how Nemera’s answer – the Symbioze® on-body injector – fulfils these needs.
INJECTION
IMPROVING CLINICAL OUTCOMES WITH A PATIENT-CENTRIC AND REUSABLE PEN PLATFORM
Cécile Gross and Radosław Romańczuk discuss Nemera’s Pendura AD pen platform and present case studies demonstrating how it can be tailored to address the user’s needs and meet pharma industry constraints.
Top